Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma
  • Hearing Loss, Sensorineural
  • Nasopharyngeal Neoplasms

abstract

  • There was a significant increase in risk of SNHL among patients receiving > 48 Gy, suggesting a threshold in cochlear radiation dose-response in the setting of combined modality therapy. This dose should serve as a Dmean constraint maximum for intensity-modulated radiotherapy treatment of nasopharynx carcinoma.

publication date

  • February 15, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.21683

PubMed ID

  • 16421885

Additional Document Info

start page

  • 820

end page

  • 9

volume

  • 106

number

  • 4